TABLE 6. Incidence of CIN by Postdose Sampling Time Point

Increase of >0.5 mg/dL in SCrIncrease of >25% in SCrDecrease of >25% in eGFR
Iopamidol-370Iodixanol-320Iopamidol-370Iodixanol-320Iopamidol-370Iodixanol-320
*CMH test to test overall treatment effect.
Postdose time ranges in hours, n/N (%)
    45 to 715/170 (2.9)13/175 (7.4)11/170 (6.5)22/175 (12.6)6/170 (3.5)17/175 (9.7)
    71 to 964/27 (14.8)1/29 (3.4)8/27 (29.6)4/29 (13.8)5/27 (18.5)4/29 (13.8)
    >960/70/61/7 (14.3)0/61/7 (14.3)0/6
P*0.3280.4170.125